APRE · Forms 3, 4, 5
Insider trades at Aprea Therapeutics, Inc.
No open-market insider buys or sells at Aprea Therapeutics, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Aprea Therapeutics, Inc. (APRE) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Aprea Therapeutics, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Michael Grissinger | Director | Award | 3,135 | Form 4 | |||
| Gabriela Gruia | Director | Award | 3,135 | Form 4 | |||
| Richard Peters | Director | Award | 3,135 | Form 4 | |||
| John B Henneman III | Director | Award | 3,135 | Form 4 | |||
| Jean-Pierre Bizzari | Director | Award | 3,135 | Form 4 | |||
| Marc Duey | Director | Award | 3,135 | Form 4 | |||
| Rifat Pamukcu | Director | Award | 3,135 | Form 4 | |||
| Bernd R. Seizinger | Director | Award | 3,135 | Form 4 | |||
| John P. Hamill | SrVP/CFO/Prin Fin & Acct Ofcr | Options or other derivatives | Form 4 | ||||
| Richard Peters | Director | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.